Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsStem CellsStem Cell TransplantationBlood Component RemovalHematopoietic Stem CellsCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionAdult Stem CellsRecurrenceCytophagocytosisCarmustineEmbryonic Stem CellsIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineCord Blood Stem Cell TransplantationHodgkin DiseaseDisease-Free SurvivalTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsSurvival RateWhole-Body IrradiationCell DifferentiationTime FactorsInfectionSurvival AnalysisLymphoma, T-CellDoxorubicinHistocompatibilityPlatelet CountPOEMS SyndromeBlood CellsHistocompatibility TestingPrednisoneCarboplatinBlood Cell CountImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineRecombinant ProteinsLeukemiaFollow-Up StudiesAntineoplastic AgentsBone Marrow PurgingLymphomaCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesMesenchymal Stem Cell TransplantationImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationLymphocyte DepletionBone MarrowT-LymphocytesLeukocytes, MononuclearCell SeparationHematologic DiseasesPluripotent Stem CellsHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsFlow CytometryLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA Antigens